Harrington Discovery Institute Researchers Identify New Drug Targets for Hard-to-Treat Cancers
The Next Frontier in Cancer Therapy: Beyond Surface Receptors For decades, the “gold standard” of targeted cancer therapy has been to attack growth factor receptors—the cellular “antennae” that tell a tumor to grow. By blocking these receptors, such as HER2 in breast cancer or EGFR in lung cancer, doctors have successfully slowed disease progression for … Read more